Sujal Shah, Chief Executive Officer at CymaBay Therapeutics, Inc. (CBAY), bought 5,000 shares at $5.50 ($28K) on 2019-09-20, disclosed to the SEC on 2019-09-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.50 | 1,900 | $10K | 37.8% |
| 2 | $5.55 | 3,100 | $17K | 62.2% |
| Total | $5.53 avg | 5,000 | $28K | 100% |
| Filing → |
| CBAY | SELL | 2023-10-10 | $1.8M | — | Filing → |
| CBAY | BUY | 2022-06-07 | $200K | — | Filing → |
| CBAY | BUY | 2019-10-15 | $22K | — | Filing → |